Characteristics, Outcomes and Predictors of Long-Term Mortality for Patients Hospitalized for Acute Heart Failure: A Report From the Korean Heart Failure Registry.
10.4070/kcj.2011.41.7.363
- Author:
Dong Ju CHOI
1
;
Seongwoo HAN
;
Eun Seok JEON
;
Myeong Chan CHO
;
Jae Joong KIM
;
Byung Su YOO
;
Mi Seung SHIN
;
In Whan SEONG
;
Youngkeun AHN
;
Seok Min KANG
;
Yung Jo KIM
;
Hyung Seop KIM
;
Shung Chull CHAE
;
Byung Hee OH
;
Myung Mook LEE
;
Kyu Hyung RYU
Author Information
1. Department of Internal Medicine, Seoul National University College of Medicine, Bundang Hospital, Seongnam, Korea.
- Publication Type:Original Article
- Keywords:
Heart failure;
Registries;
Outcome
- MeSH:
Anemia;
Angiotensin Receptor Antagonists;
Angiotensins;
Female;
Heart;
Heart Failure;
Hospitalization;
Humans;
Hyponatremia;
Korea;
Multivariate Analysis;
Myocardial Ischemia;
Natriuretic Peptide, Brain;
Peptide Fragments;
Prognosis;
Registries;
Risk Factors;
Stroke Volume
- From:Korean Circulation Journal
2011;41(7):363-371
- CountryRepublic of Korea
- Language:English
-
Abstract:
BACKGROUND AND OBJECTIVES: Acute heart failure (AHF) is associated with a poor prognosis and it requires repeated hospitalizations. However, there are few studies on the characteristics, treatment and prognostic factors of AHF. The aims of this study were to describe the clinical characteristics, management and outcomes of the patients hospitalized for AHF in Korea. SUBJECTS AND METHODS: We analyzed the clinical data of 3,200 hospitalization episodes that were recorded between June 2004 and April 2009 from the Korean Heart Failure (KorHF) Registry database. The mean age was 67.6+/-14.3 years and 50% of the patients were female. RESULTS: Twenty-nine point six percent (29.6%) of the patients had a history of previous HF and 52.3% of the patients had ischemic heart disease. Left ventricular ejection fraction (LVEF) was reported for 89% of the patients. The mean LVEF was 38.5+/-15.7% and 26.1% of the patients had preserved systolic function (LVEF > or =50%), which was more prevalent in the females (34.0% vs. 18.4%, respectively, p<0.001). At discharge, 58.6% of the patients received beta-blockers (BB), 53.7% received either angiotensin converting enzyme-inhibitors or angiotensin receptor blockers (ACEi/ARB), and 58.4% received both BB and ACEi/ARB. The 1-, 2-, 3- and 4-year mortality rates were 15%, 21%, 26% and 30%, respectively. Multivariate analysis revealed that advanced age {hazard ratio: 1.023 (95% confidence interval: 1.004-1.042); p=0.020}, a previous history of heart failure {1.735 (1.150-2.618); p=0.009}, anemia {1.973 (1.271-3.063); p=0.002}, hyponatremia {1.861 (1.184-2.926); p=0.007}, a high level of serum N-terminal pro-B-type natriuretic peptide (NT-proBNP) {3.152 (1.450-6.849); p=0.004} and the use of BB at discharge {0.599 (0.360-0.997); p=0.490} were significantly associated with total death. CONCLUSION: We present here the characteristics and prognosis of an unselected population of AHF patients in Korea. The long-term mortality rate was comparable to that reported in other countries. The independent clinical risk factors included age, a previous history of heart failure, anemia, hyponatremia, a high NT-proBNP level and taking BB at discharge.
